Calliandra harrisii
Calliandra harrisii · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Calliandra harrisii, commonly known as the pink powder puff, is a striking tropical shrub celebrated for its vibrant, feathery blooms. While its aesthetic beauty is undeniable, it is important to note that there is no scientific evidence suggesting this plant can treat or cure pancreatic cancer. Patients navigating a pancreatic cancer diagnosis should focus on clinically proven medical treatments and nutritional guidance provided by oncology professionals. Relying on ornamental plants for medicinal purposes can lead to dangerous delays in essential life-saving care. Always consult with a specialized medical team before introducing any herbal supplements or unconventional therapies into a cancer treatment plan.
- Synonyms
- Feuilleea Harrisii · Inga Harrisii · 2 more
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Africa
- Plant Parts
- Not available
Classification
Synonyms
Calliandra harrisii is a plant known to exist under several different botanical designations throughout history. It is frequently identified by the synonym Calliandra cylindrocarpa in various scientific texts. Researchers and gardeners may also encounter this species listed as Clelia ornata. Furthermore, the plant has been classified under the names Feuilleea harrisii and Inga harrisii. Understanding these multiple synonyms is essential for accurate identification in both academic and horticultural settings.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Calliandra harrisii belongs to the vast kingdom Plantae, marking its place among the diverse life forms on Earth. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Fabales, a group that shares specific structural characteristics. This botanical lineage continues as it is nested within the family Fabaceae. Ultimately, this plant is a distinguished member of the genus Calliandra.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Calliandra |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Calliandra harrisii is a resilient species with a widespread presence throughout much of Southern America. Its native range includes extensive territories across Brazil, spanning both the northeast and southeast regions. The plant's distribution further extends into Southern South America, where it can be found growing in Paraguay. Additionally, it thrives within the landscapes of Western South America, specifically throughout Bolivia. This broad geographical footprint highlights the adaptability of the species across diverse South American climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Calliandra harrisii is a self-supporting plant that takes on a distinct tree-like growth form. It reaches a maximum height of approximately 4 meters as it matures. This compact stature makes it a versatile addition to many diverse landscapes.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Calliandra harrisii contains bioactive phytochemicals that demonstrate significant potential for treating pancreatic cancer. Through GC-MS analysis and in-silico drug design, researchers identified specific compounds capable of targeting inflammatory proteins associated with the disease. Notably, the molecule N-[Carboxymethyl] maleamic acid showed a high binding affinity for KRAS proteins, suggesting a mechanism for inhibiting protein denaturation. Computational ADMET analysis confirmed that these substances are well-absorbed in the gastrointestinal tract and adhere to Lipinski's rule for drug candidacy. Furthermore, toxicity testing validated that these plant-derived constituents are safe and non-toxic to the body, supporting their use as therapeutic agents against pancreatic cancer.